E-mail| Contact Us| Volunteer| Make A Gift| En Español| Employees




Patients & Visitors

Accountable Care

Patients & Visitors > Accountable Care > Lancaster General Health CCC Public Reporting Information

Lancaster General Health CCC Public Reporting Information

 

ACO Name and Location

Lancaster General Health Community Care Collaborative, LLC
555 North Duke St.
PO Box 3555
Lancaster, PA 17604


ACO Primary Contact

Primary Contact Name Kevin Bogari
Primary Contact Phone Number 717-544-5511
Primary Contact Email Address info@lghealth.org


 

Organizational Information

ACO participants:

 

ACO Participants ACO Participant in Joint Venture (Enter Y or N)
Lancaster General Health - Columbia Center N
Lancaster General Hospital N
Lancaster General Medical Group N
The Heart Group of Lancaster General Health N

 

ACO Governing Body


Member

Member's Voting Power

Membership Type

ACO Participant TIN Legal Business Name/DBA, if Applicable

Last Name

First Name

Title/Position

Foley, MD

T. Raymond

Voting Member / Chair

1

ACO Participant Representative

Lancaster General Medical Group

Bogari

Kevin

Voting Member / President

1

ACO Participant Representative

Lancaster General Hospital

Wood, MD

John C. 

Voting / Medical Director

1

ACO Participant Representative

Lancaster General Hospital

Addis, MD

Christopher T.

Voting Member

1

ACO Participant Representative

Lancaster General Hospital

Shepherd, MD

Rebecca M.

Voting Member

1

ACO Participant Representative

Lancaster General Medical Group

Kraybill, MD

Leon S. 

Voting Member

1

ACO Participant Representative

Lancaster General Hospital

Young, MD

Brian J.

Voting Member

1

ACO Participant Representative

Lancaster General Health - Columbia Center

Pulliam, MD

R. Ward

Voting Member

1

ACO Participant Representative

The Heart Group of LG Health

Tifft, MD

Stephen W.

Voting Member

1

ACO Participant Representative

Lancaster General Medical Group

Wesbury, PhD

Stuart

Voting Member

1

Medicare Beneficiary

N/A

Legenstein

Walt

Voting Member

1

Community Representative

N/A

Polin, MD

David G.

Voting Member

1

Community Provider

EMG Group

Boben, MD

William R.

Voting Member

1

Community Provider

Lancaster Pediatric Associates

Yingling, MD

Bryan L.

Voting Member

1

Community Provider

May/Grant Associates

Pavlica, MD

Michael R. 

Voting Member

1

Community Provider

Family Eye Group

Johnsen-Martin, DO

Kirsten

Voting Member

1

Community Provider

SouthEast Lancaster Health Services

Briguglio, MD

John

Voting Member

1

Community Provider

Lancaster Radiology Associates

Kager, MD

Christopher D.

Voting Member

1

Community Provider

Lancaster NeuroScience and Spine Associates

Harrold, MD

Joan K. 

Voting Member

1

Community Provider

Palliative Medicine Consultants

Horvat, MD

Craig P.

Voting Member

1

Community Provider

Pulmonary Associates of Lancaster

 

Key ACO clinical and administrative leadership:


Kevin Bogari ACO Executive
John Wood Medical Director
Elizabeth Katz Compliance Officer
Michael Ripchinski Quality Assurance/Improvement Officer

Associated Committees & Committee Leadership

 

Committee Name Committee Leader Name and Position
Quality Committee Rodney Brenneman, MD - Chair
Finance Committee Stephen Tifft, MD – Chair
Clinical Integration Committee David Polin, MD - Chair

 

Types of ACO participants, or combinations of participants, that formed the ACO:

  • Partnerships or joint venture arrangements between hospitals and ACO professionals

Shared Savings and Losses

Amount of Shared Savings/Losses:

  • First Agreement Period
    • Performance Year 2016, $0
    • Performance Year 2015, $0
    • Performance year 2014, $0

Shared Savings Distribution

  • First Agreement Period
  • Performance Year 2016
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2015
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A
  • Performance Year 2014
    • Proportion invested in infrastructure: N/A
    • Proportion invested in redesigned care processes/resources: N/A
    • Proportion of distribution to ACO participants: N/A

Quality Performance Results

2016 Quality Performance Results 
 

ACO#

Measure Name

Rate

ACO Mean

ACO-1

CAHPS: Getting Timely Care, Appointments, and Information 

84.29

79.9

ACO-2

CAHPS: How Well Your Providers Communicate 

94.89

92.63

ACO-3

CAHPS: Patients’ Rating of Provider 

92.74

91.93

ACO-4

CAHPS: Access to Specialists 

84.53

83.52

ACO-5

CAHPS: Health Promotion and Education

62.35

60

ACO-6

CAHPS: Shared Decision Making 

78.35

75.28

ACO-7

CAHPS: Health Status/Functional Status 

74.51

71.82

ACO-34

CAHPS: Stewardship of Patient Resources 

24.34

27.52

ACO-8

Risk Standardized, All Condition Readmissions

13.5

14.7

ACO-35

Skilled Nursing Facility 30-day All-Cause Readmission measure (SNFRM)

15.39

18.17

ACO-36

All-Cause Unplanned Admissions for Patients with Diabetes

39.26

53.2

ACO-37

All-Cause Unplanned Admissions for Patients with Heart Failure

54.4

75.23

ACO-38

All-Cause Unplanned Admissions for Patients with Multiple Chronic Conditions

43.62

59.81

ACO-9

Ambulatory Sensitive Condition Admissions: Chronic Obstructive Pulmonary Disease or Asthma in Older Adults (AHRQ Prevention Quality Indicator (PQI) #5)

6.75

9.27

ACO-10

Ambulatory Sensitive Conditions Admissions: Heart Failure (AHRQ Prevention Quality Indicator (PQI) #8)

10.02

14.53

ACO-11

Percent of PCPs who Successfully Meet Meaningful Use Requirements

100

82.72

ACO-39

Documentation of Current Medications in the Medical Record

94.69

87.54

ACO-13

Falls: Screening for Fall Risk

55.41

64.04

ACO-14

Preventive Care and Screening: Influenza Immunization

75.17

68.32

ACO-15

Pneumonia Vaccination Status for Older Adults

88.31

69.21

ACO-16

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up

41.62

74.45

ACO-17

Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up

94.42

90.98

ACO-18

Preventive Care and Screening: Screening for Clinical Depression and Follow-up Plan

68.74

53.63

ACO-19

Colorectal Cancer Screening

72.9

61.52

ACO-20

Breast Cancer Screening

82.52

67.61

ACO-21

Preventive Care and Screening: Screening for High Blood Pressure and Follow-Up Documented 

91.33

76.84

ACO-42

Statin Therapy for the Prevention and Treatment of Cardiovascular Disease

66.18

77.72

ACO-27

Diabetes Mellitus: Hemoglobin A1c Poor Control 

13.51

18.24

ACO-41

Diabetes: Eye Exam

58.42

44.94

ACO-28

Hypertension: Controlling High Blood Pressure 

70.49

70.52

ACO-30

Ischemic Vascular Disease: Use of Aspirin or Another Antithrombotic

81.14

85.05

ACO-31

Heart Failure: Beta-Blocker Therapy for Left Ventricular Systolic Dysfunction (LVSD)

89.88

88.67

ACO-33

Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - for patients with CAD and Diabetes or Left Ventricular Systolic Dysfunction (LVEF<40%)

63.26

79.67


Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public reporting due to low samples.

Note: In the Quality Performance Results file(s) above, search for “Lancaster General Health Community Care Collaborative, LLC” to view the quality performance results. This ACO can also be found by using the ACO ID A66745 in the public use files on data.cms.gov.
 

Payment Rule Waivers

No, our ACO does not use the SNF 3-Day Rule Waiver



 

Contact Us:

1-888-LGH-INFO (544-4636) Have a question?
Follow us online.